Neuraminidase family enzymes that hydrolyze the terminal sialic acid linkage in biomolecules are involved in various immune responses. We previously showed that Neuraminidase catalyzes the removal of sialic acid residues from glycoproteins, glycolipids and oligosaccharides (Miyagi & Yamaguchi, 2012) . The mammalian neuraminidase family comprises four proteins with distinct subcellular localization and enzymatic profiles. These proteins are implicated in various biological processes such as neuronal and muscle cell differentiation (Da Silva, Hasegawa, Miyagi, Dotti, & Abad-Rodriguez, 2005; Fanzani et al., 2003) , apoptosis (Wada et al., 2007) , tumorigenesis (Shiozaki, Yamaguchi, Sato, & Miyagi, 2009 ) and immune responses (Katoh et al., 2010) . We recently showed that the association of CD44 with its ligand, hyaluronic acid, was impaired in neuraminidase 1 (Neu1)-deficient mouse strain, SM/J (Katoh et al., 2010) . Consistent with the importance of CD44 in the local migration of Th2 cells (Katoh et al., 2011; Nishimura et al., 2016) , Th2-type allergic airway inflammation was extremely diminished in SM/J mice (Katoh et al., 2010) .
Similar to the role of Neu1 in tumorigenesis (Haxho, Neufeld, & Szewczuk, 2016) , the involvement of neuraminidase 3 (Neu3) in head and neck squamous cell carcinoma associated with lymph node metastasis was reported (Shiga et al., 2015) . The role of Neu3 in immune cell functions was further indicated in our previous studies, showing that both Neu3 and Neu1 are differentially expressed in Th1 and Th2 cells (Katoh et al., 2011) . Therefore, not only Neu1 but also Neu3 potentially plays a role in T-cell-mediated immune responses.
Although the role of Neu1 in polarized Th2 cells has been suggested before (Katoh et al., 2011) , the function of neuraminidases in the differentiation of T-cell subsets is unknown. In this study, we observed higher expression of Neu3 in induced Treg (iTreg) cells and further investigated the role of Neu3 in iTreg differentiation.
| RESULTS
The expression levels of neuraminidases in T-cell subsets were compared. Antigen-specific Th1, Th2, Th17 and iTreg cells were differentiated from naïve CD4 + T cells of DO11.10 × Rag2 −/− mice through in vitro stimulation culture, as described previously (Kaminuma et al., 2012; Watanabe, Kaminuma, Kitamura, & Hiroi, 2016) . Successful polarization of the resulting Th1, Th2 and Th17 cells was confirmed by intracellular cytokine staining. The specific expression of FoxP3, CD25 and cytotoxic T lymphocyte-associated antigen (CTLA)-4 was observed in iTreg cells, as shown in the previous report (Watanabe et al., 2016) . Relative expression of Neu1 was higher, although not significantly, in Th2 cells than in naïve CD4 + T, Th1, Th17 and iTreg cells ( Figure 1a ).
However, the expression of Neu3 was much higher in iTreg cells than other T-cell subsets ( Figure 1b ). Although we previously observed higher expression of Neu3 in Th2 cells than in Th1 cells (Katoh et al., 2011) , in this study, the difference was not statistically significant. Neu2 and Neu4 were not detectable in any of these cells, under our experimental conditions. Next, the expression of Neu3 was investigated in splenic Treg cells. Based on flow cytometric detection of EGFP fluorescence, we found that approximately 5% of splenic CD3 + CD4
+ cells in FoxP3-DTR/EGFP mice express FoxP3. (Figure 3a) , the expression of FoxP3 was significantly upregulated by Neu3 (Figure 3b) . However, the expression of another Treg-related molecule, CTLA-4, was not affected by the introduction of Neu3 (Figure 3c ). Consistently, an increase in Neu3 expression during iTreg differentiation seemed to be a prerequisite for the upregulation of FoxP3 ( Figure S1 ).
| DISCUSSION
Our present findings suggest that Neu3 is involved in the differentiation of iTreg cells by the augmentation of FoxP3 expression. Analogous to Neu1, the carcinogenic function of Neu3 has been reported previously. Elevated expression of Neu3 was seen in various neoplasms such as ovarian, prostate, colon and renal cancers (Miyagi & Yamaguchi, 2012) . Neu3 expression in colon cancer cells increased Bcl-2 and decreased caspase expression and the resulting suppression of apoptosis (Kakugawa et al., 2002) . Many other molecules associated with carcinogenesis and malignancy, such as epidermal growth factor, focal adhesion kinase, integrin-linked kinase, Shc and integrins, have been shown to be regulated by Neu3 (Miyagi & Yamaguchi, 2012) . As Treg cells are involved in the suppression of antitumor immune responses (Whiteside, 2012) , the enhancement of Treg cell differentiation may be a novel Neu3-mediated mechanism of tumor progression and metastasis. Despite their common features, there are several differences in structure, distribution and function among the neuraminidase family molecules (Miyagi & Yamaguchi, 2012) . Specifically, the amino acid identity between murine Neu1 and Neu3 is only 26%. The main subcellular localization site of Neu1 is lysosomes, whereas Neu3 is mainly located in the plasma membrane. Neu3 preferentially hydrolyzes gangliosides, which are barely affected by Neu1. In addition to our earlier study comparing Th1 and Th2 cells (Katoh et al., 2011) , in this study, we found the differential expression pattern of Neu1 and Neu3 in T-cell subsets. In contrast to the preferential expression of Neu1 in Th2 cells, the strong upregulation of Neu3 was seen in iTreg cells. In human T cells, Nan et al. reported that the expression of Neu1, but not Neu3, was upregulated upon TCR-mediated stimulation (Nan, Carubelli, & Stamatos, 2007) . Although part of our observations seems to contradict the results of Nan et al., only a small portion of naïve T cells could differentiate into iTreg cells. The selective upregulation of Neu3 in iTreg cells might not be detectable in the experiments of Nan et al., because they used total peripheral T lymphocytes.
The mechanism of selectivity in Neu3 expression is still unclear. Although expression of Neu3 is often seen in tumor cells (Miyagi & Yamaguchi, 2012) , the regulatory mechanisms behind Neu3 expression are not fully clarified. Yamaguchi et al. showed that Neu3 gene transcription is regulated by Sp1 and Sp3 transcription factors (Yamaguchi et al., 2010) . The activation of Neu3 by epidermal growth factor and hypoxia-inducible factor has also been reported (Scaringi et al., 2013) . Furthermore, the involvement of ganglioside in Treg differentiation has also been suggested (Zhao, Ciric, Yu, Zhang, & Rostami, 2010) . However, the interaction of these factors with Treg-inducible signaling cascades needs further investigation. The mechanism underlying Neu3-dependent upregulation of FoxP3 is another unresolved issue. The expression of FoxP3 is regulated by many signaling cascades. TCR and costimulatory molecules, together with IL-2 and TGFβ receptor signaling pathways, are involved in regulating FoxP3 expression (Barbi, Pardoll, & Pan, 2015) . However, the modification of cell surface molecules and activation of transmembrane signaling by Neu3 upon interaction with other signaling molecules are known (Miyagi & Yamaguchi, 2012) . As we observed the selective Neu3 upregulation in activated Treg cells, in our present study, TCR and/or costimulatory signaling molecules required for initial T-cell activation are candidate targets of Neu3-mediated upregulation of FoxP3 expression.
In conclusion, selective upregulation of Neu3 during the development of iTreg cells plays a role in inducing expression of FoxP3. Neu3-mediated Treg cell differentiation may be a potential target for novel therapeutic strategies against cancer and other immunological diseases.
| EXPERIMENTAL PROCEDURES

| Animals
Male BALB/c mice, 6-8 weeks of age, were obtained from Japan SLC, Inc. (Hamamatsu, Japan). Ovalbumin residues 323-339-specific T-cell receptor-expressing DO11.10, FoxP3-DTR/EGFP and Rag2 −/− mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). Experimental procedures used in this study were approved by the Animal Use and Care Committee of Tokyo Metropolitan Institute of Medical Science.
| In vitro differentiation of T cells
OVA-specific Th1, Th2, Th17 and iTreg cells were generated from DO11.10 × RAG2 −/− mice, following methods described previously (Kaminuma et al., 2012; Watanabe et al., 2016) . Briefly, CD4 + T cells were isolated from spleen cells by a positive selection using CD4 microbeads with a magnetic cell sorting system (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). The purity of the resulting cells was >95% as determined by flow cytometry. The naive CD4 + T cells were cultured in Dulbecco's modified Eagle's medium (Sigma, St. Louis, MO, USA) supplemented with 10% FBS in the presence of 100 μg/ ml ovalbumin, X-ray-irradiated splenocytes of BALB/c mice and 10 U/ml recombinant IL-2 (Shionogi, Osaka, Japan). The respective reagents were added for the polarization of each T-cell subset, as described previously (Kaminuma et al., 2012; Watanabe et al., 2016) . After 7-10 days of stimulation, cells were harvested, purified by centrifugation on Ficoll-Paque (GE Healthcare BioSciences, Pittsburgh, PA, USA) and then used as each T-cell subset.
| Introduction of Neu3 in T cells
For protein over-expression, the coding region (266-1522 bp) of murine Neu3 cDNA (NM_16720) was subcloned into the lentivirus vector, as described previously (Kaminuma et al., 2009) . The lentivirus pseudotyped with vesicular stomatitis virus G glycoprotein, expressing Neu3 with an internal ribosomal entry site sequence followed by the fluorescent protein, Venus, and its control virus without a Neu3 cDNA insert, were prepared, as described previously (Kaminuma et al., 2009) . Cells were infected with viral stock solutions at a multiplicity of infection (MOI) of 50-200, at 48 hr after the start of culture. After 7-10 days of stimulation, lentivirus infection-positive CD3 + CD4 + cells were purified with a FACSAria cell sorting system (BD Bioscience, Franklin Lakes, NJ, USA). To normalize the experimental conditions between control virus-and Neu3-expressing virus-infected groups, the cells with similar levels of Venus fluorescence under several MOIs of virus infection conditions (~2% cells were Venus-positive) were processed for cell sorting from both groups.
| Quantitative RT-PCR analysis
After reverse transcription of total RNA using random primers (Toyobo, Osaka, Japan) and SuperScript III reverse transcriptase (Thermo Fisher Scientific, Inc., Waltham, MA, USA), quantitative real-time RT-PCR for Neu1, Neu3, FoxP3 and CTLA-4 was carried out using Assayon-Demand TM Gene Expression Products (TaqMan ® MGB probes, Thermo Fisher Scientific, Inc.) with a CFX96 TM Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA), as described previously (Katoh et al., 2011) .
| Statistics
Results are presented as mean ± standard error. Statistical analysis was carried out by Student's t test and one-way analysis of variance with Dunnet's method. p < .05 was used to show statistical significance.
